ReviewProceedings (Baylor University. Medical Center)2025

Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials.

Alaa Abdrabou Abouelmagd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.